Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries

Wyeth

Status: Completed

Conditions: Transplantation

Treatments: Drug: Sirolimus

Study type: Observational

Funder types: Industry

Identifiers

NCT00195195

0468-101157

Details and patient eligibility

About

The purpose of this study is to gather information about the long-term effects and safety of treatment with Rapamune in transplant patients.

Enrollment: 66 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Transplantation patients treated with sirolimus (Rapamune).

Exclusion criteria

• Patients must be able to give informed consent.

Trial design

66 participants in 1 patient group

1

Description:

Sirolimus

Treatment:

Drug: Sirolimus